Realcan Pharmaceutical Group Co Ltd - Class A

SZSE:002589 (China)   Class A
¥ 2.45 (-0.81%) Apr 19
At Loss
P/B:
0.67
Market Cap:
¥ 3.69B ($ 509.21M)
Enterprise V:
¥ 2.01B ($ 276.95M)
Volume:
18.81M
Avg Vol (2M):
28.42M
Volume:
18.81M
At Loss
Avg Vol (2M):
28.42M

Business Description

Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Name Current Vs Industry Vs History
Cash-To-Debt 1.44
Equity-to-Asset 0.32
Debt-to-Equity 0.71
Debt-to-EBITDA -2.46
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.42
Distress
Grey
Safe
Beneish M-Score -2.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.62
9-Day RSI 35.38
14-Day RSI 39.27
6-1 Month Momentum % -15
12-1 Month Momentum % -25.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.05
Quick Ratio 0.99
Cash Ratio 0.49
Days Inventory 51.02
Days Sales Outstanding 233.2
Days Payable 391.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate -44.3
Shareholder Yield % 17.27
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Realcan Pharmaceutical Group Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 7,519.624
EPS (TTM) (¥) -1.271
Beta 0.53
Volatility % 29.66
14-Day RSI 39.27
14-Day ATR (¥) 0.145372
20-Day SMA (¥) 2.8025
12-1 Month Momentum % -25.32
52-Week Range (¥) 2.05 - 3.96
Shares Outstanding (Mil) 1,504.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Realcan Pharmaceutical Group Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Realcan Pharmaceutical Group Co Ltd Stock Events

Financials Calendars
Event Date Price(¥)
No Event Data

Realcan Pharmaceutical Group Co Ltd Frequently Asked Questions

What is Realcan Pharmaceutical Group Co Ltd(SZSE:002589)'s stock price today?
The current price of SZSE:002589 is ¥2.45. The 52 week high of SZSE:002589 is ¥3.96 and 52 week low is ¥2.05.
When is next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589)?
The next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is .
Does Realcan Pharmaceutical Group Co Ltd(SZSE:002589) pay dividends? If so, how much?
Realcan Pharmaceutical Group Co Ltd(SZSE:002589) does not pay dividend.

Press Release

Subject Date
No Press Release